nflreadr
The nflverse data loader, whose releases are dictated by the NFL calendar and CRAN's archive policy
A side-by-side editorial comparison of bayestools and medrobust — release velocity, themes, recent moves, and the top alternatives to consider.
The JAGS toolkit under RoBMA, shipping the standardization machinery its downstream rewrite needed
BayesTools provides the shared JAGS fitting, prior and summary infrastructure that the author's meta-analysis packages build on. The 0.2.x line filled in modeling primitives — prior_mixture() and mixed-posterior objects in 0.2.18, expression-valued priors and lme4-style uncorrelated random effects in 0.2.20, then a run of small diagnostic fixes for mixture and spike-and-slab priors. Version 0.3.0 in May 2026 adds automatic standardization of continuous predictors, default priors for unspecified factor and continuous terms, and functions to transform prior and posterior samples back to the original scale.
medrobust made its partial-identification bounds usable by giving them confidence intervals.
medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.
BayesTools provides the shared JAGS fitting, prior and summary infrastructure that the author's meta-analysis packages build on. The 0.2.x line filled in modeling primitives — prior_mixture() and mixed-posterior objects in 0.2.18, expression-valued priors and lme4-style uncorrelated random effects in 0.2.20, then a run of small diagnostic fixes for mixture and spike-and-slab priors. Version 0.3.0 in May 2026 adds automatic standardization of continuous predictors, default priors for unspecified factor and continuous terms, and functions to transform prior and posterior samples back to the original scale.
This package's releases are best read against what depends on them. The 0.2.x fixes track features appearing in RoBMA one version later, and 0.3.0 landed a single day before RoBMA 4.0.0 — the standardization and sample-transformation functions are the substrate that rewrite needed. The direction of the work is toward sensible defaults: default priors by predictor type, automatic standardization for sampling stability, and transformation back to interpretable scale so the convenience does not cost the user their units.
Given how tightly its releases track downstream needs, the next version is most likely driven by gaps surfacing in RoBMA 4.0.x rather than by independent feature work.
medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.
The pattern is deliberate and symmetric: 0.3.0 shipped the mediator-side example on NCHS natality data, 0.4.0 its exposure-side mirror on NHANES, each demonstrating what the bounds do when reporting accuracy is allowed to depend on the outcome. Alongside that runs a consistent concern with failing usefully rather than loudly — bound_ne() returns NA bounds with a machine-readable reason and a typed condition instead of aborting, so a simulation replicate is recorded rather than lost, and non-finite endpoint standard errors produce a documented NA rather than a silent one. That is a package expecting to be run thousands of times inside someone else's loop.
Both identification paths now have a dataset, a vignette and interval coverage, so the next release is most likely the deferred CRAN submission rather than new methodology.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either bayestools or medrobust.
The nflverse data loader, whose releases are dictated by the NFL calendar and CRAN's archive policy
Fine-mapping workhorse susieR spends its releases hunting null-effect trimming bugs
A rank-based gene signature scorer that has grown by adapting to whatever object format single-cell R uses next
A diagnostic package that generalized past its own name, then learned to say which kind of separation it found
A bias-reduction package reaches 1.0 by adding an estimator built for high-dimensional logistic regression
RoBMA 4.0 tears out its own constructor surface and rebuilds on one class hierarchy
See all bayestools alternatives → · See all medrobust alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. bayestools and medrobust are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. bayestools and medrobust are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top bayestools alternatives in Analytics are ranked by recent ship velocity. Browse the "bayestools alternatives" section above for the current picks, or visit /alternatives/bayestools for the full list with editorial commentary on each.
Top medrobust alternatives in Analytics are ranked by recent ship velocity. Browse the "medrobust alternatives" section above for the current picks, or visit /alternatives/medrobust for the full list with editorial commentary on each.